Invention Grant
- Patent Title: Humanized or chimeric CD3 antibodies
-
Application No.: US16544376Application Date: 2019-08-19
-
Publication No.: US11613575B2Publication Date: 2023-03-28
- Inventor: Edward Norbert Van Den Brink , Joost J. Neijssen , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Isil Altintas , Paul Parren , Rik Rademaker
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: DKPA201400009 20140109,WOPCT/EP2014/050340 20140109,WOPCT/EP2014/064326 20140704
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07K16/28 ; C07K16/32 ; C07K16/10 ; C07K16/42 ; G01N33/68 ; A61K39/00
Abstract:
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
